Trademark: 87650798
Word
UDIIFTRI
Status
Dead
Status Code
605
Status Date
Friday, July 2, 2021
Serial Number
87650798
Mark Type
4000
Filing Date
Wednesday, October 18, 2017
Published for Opposition
Tuesday, May 22, 2018
Abandoned Date
Thursday, July 1, 2021

Trademark Owner History
H. Lundbeck A-S - Owner At Publication

Classifications
5 (Based on 44(d) Priority Application) (Based on Intent to Use) Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes
10 (Based on 44(d) Priority Application) (Based on Intent to Use) Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Trademark Events
Jul 2, 2021
Abandonment Notice E-Mailed - After Publication
Jul 2, 2021
Abandonment - After Publication
Jul 1, 2021
Teas Express Abandonment Received
Dec 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2020
Extension 5 Granted
Nov 12, 2020
Extension 5 Filed
Nov 23, 2020
Case Assigned To Intent To Use Paralegal
Nov 12, 2020
Teas Extension Received
Jul 8, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 6, 2020
Extension 4 Granted
Jul 6, 2020
Extension 4 Filed
Jul 6, 2020
Teas Extension Received
Dec 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 4, 2019
Extension 3 Granted
Dec 4, 2019
Extension 3 Filed
Dec 4, 2019
Teas Extension Received
Jun 20, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2019
Extension 2 Granted
Jun 18, 2019
Extension 2 Filed
Jun 18, 2019
Teas Extension Received
Dec 25, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2018
Extension 1 Granted
Dec 21, 2018
Extension 1 Filed
Dec 21, 2018
Teas Extension Received
Jul 17, 2018
Noa E-Mailed - Sou Required From Applicant
May 22, 2018
Official Gazette Publication Confirmation E-Mailed
May 22, 2018
Published For Opposition
May 2, 2018
Notification Of Notice Of Publication E-Mailed
Apr 13, 2018
Electronic Record Review Complete
Mar 30, 2018
On Hold - Electronic Record Review Required
Mar 26, 2018
Approved For Pub - Principal Register
Mar 26, 2018
Examiner's Amendment Entered
Mar 26, 2018
Notification Of Examiners Amendment E-Mailed
Mar 26, 2018
Examiners Amendment E-Mailed
Mar 26, 2018
Examiners Amendment -Written
Mar 11, 2018
Notification Of Non-Final Action E-Mailed
Mar 11, 2018
Non-Final Action E-Mailed
Mar 11, 2018
Non-Final Action Written
Feb 21, 2018
Teas/Email Correspondence Entered
Feb 21, 2018
Correspondence Received In Law Office
Feb 16, 2018
Assigned To Lie
Feb 9, 2018
Teas Response To Office Action Received
Jan 29, 2018
Notification Of Non-Final Action E-Mailed
Jan 29, 2018
Non-Final Action E-Mailed
Jan 29, 2018
Non-Final Action Written
Jan 26, 2018
Assigned To Examiner
Oct 27, 2017
New Application Office Supplied Data Entered In Tram
Oct 21, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24